Showing results (301-310 of 412) with videos related to
Sort By:
Pageof 42
Neuro-Oncology|May 15, 2015
Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigueBrandi R Page, Edward G Shaw, Lingyi Lu, et al.Nature|September 29, 2006
Bose-Einstein condensation of exciton polaritonsJ Kasprzak, M Richard, S Kundermann, et al.Transplantation and Cellular Therapy|March 11, 2023
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid LeukemiaJennifer Marvin-Peek, Emily F Mason, Ashwin Kishtagari, et al.Experimental Hematology|September 19, 2025
A 30-gene classifier distinguishes low-risk MDS HSPCs from healthy HSPCsPawan Bhat, Joseph C Van Amburg, Chad R Potts, et al.European Journal of Public Health|February 20, 2021
Identifying the views of adolescents in five European countries on the drivers of obesity using group model buildingNatalie Savona, Talia Macauley, Anaely Aguiar, et al.Experimental Hematology|February 22, 2021
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinibMatthew T Villaume, M Pia Arrate, Haley E Ramsey, et al.Blood Advances|October 31, 2025
Decitabine-cedazuridine in patients with MDS and TP53 mutationsSamuel Urrutia, Koji Sasaki, Alex Bataller, et al.Haematologica|October 30, 2016
Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosisJohn O Mascarenhas, Moshe Talpaz, Vikas Gupta, et al.Social Science & Medicine (1982)|January 28, 2021
Evaluation of public health interventions from a complex systems perspective: A research methods reviewElizabeth McGill, Vanessa Er, Tarra Penney, et al.Leukemia Research|January 9, 2018
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A Strickland, Aaron C Shaver, Michael Byrne, et al.Pageof 42